Search
Jun 3
Moderna CEO Stéphane Bancel walks us through Moderna and Merck's 3-year individual neoantigen therapy + Keytruda adjuvant melanoma data at #ASCO24 and Moderna's broader oncology pipeline
At Moderna's analyst meeting at #ASCO24 in Chicago, Stéphane Bancel shows the Kaplan-Meier curve separation over time for the neoantigen...
Jan 3
Moderna CEO Stéphane Bancel discusses what's ahead in 2024
Stéphane Bancel talks about Moderna's programs for COVID, RSV, CMV, cancer, and more.
Sep 13, 2023
Moderna’s Head of R&D explains how mRNA is being tested with other emerging cancer modalities
Stephen Hoge explains how Moderna is partnering on programs that include CAR-T, TCRs, bi-specifics, and in-vivo editing programs.
Sep 13, 2023
Moderna CEO Stéphane Bancel on Moderna’s business at its R&D Day in New York
Stéphane Bancel comments on the fall covid vaccine rollout, pushing into earlier stages of cancer, and rare diseases.
Jan 10, 2023
Stéphane Bancel discusses Moderna's personalized cancer vaccine at #JPM23
Moderna CEO Stéphane Bancel discusses his company's personalized cancer vaccine on Day Two of #JPM23 in San Francisco.
Jun 21, 2022
Noubar Afeyan on Moderna and Biotech Innovation
Flagship Pioneering's Noubar Afeyan describes what it was like to navigate the pandemic as Chairman of Moderna.
.png){kind=logo}
